Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Rawal Medical Journal

Unmasking the role of obesity in COVID-19: Effects on laboratory parameters, inflammatory markers and clinical outcome

View Full Paper
Ask AI
Bookmark
Share

Authors

GJGhazala JawwadGLGhulam Mustafa LodhiJAJamil Abbasi

Discussion

Loading...

Member takes

Overview

Retrospective analysis highlights higher inflammatory markers and mortality in obese COVID-19 patients.

Key Points

  • Obese COVID-19 patients had significantly higher pCO₂ levels and lower PO2 compared to non-obese patients.
  • Glycosylated hemoglobin levels were notably higher in obese individuals, indicating worse glycemic control.
  • Oxygen needs at discharge and mortality rate were both higher in obese patients compared to their non-obese counterparts.
  • Data was collected from 150 patients between July 2021 and November 2022 across two hospitals.

Cite This Study

Jawwad et al. (2025) studied this question.

synapsesocial.com/papers/68c240deb210217d6479d2a4https://doi.org/10.5455/rmj.20250328042225
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Obesity and COVID-19: Pathophysiological Insights and Pulmonary Complications in a Retrospective Cohort Study2025
  2. 2Body mass index and critical care outcomes in hospitalized COVID-19 patients—A national cohort study2025
  3. 3Outcomes of overweight and obese critically ill patients with severe acute respiratory infection2025
  4. 4P101 | Metainflammation and coagulation response of the obese patients during sepsis: an observational-prospective study2025
  5. 5The Impact of Obesity on Clostridioides difficile Infection Outcomes: A Retrospective Cohort Study2025 · 2 citations